Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Peptides that bind to MHC class II proteins in development at Zeneca

Oct. 1, 1998

Selectin inhibitors described by Sanwa Kagaku for inflammatory disorders

Oct. 1, 1998

Piperazines as inhibitors of MMPs and/or TNF-alpha prepared at Fujisawa

Oct. 1, 1998

NPS Pharmaceuticals initiates clinical trials for NPS-1776

Oct. 1, 1998

New arthritis Rx now available in Japan

Sep. 30, 1998

Selectin inhibitors under study at Kanebo

Sep. 28, 1998

TheraTech receives NIH funding for novel approach to rheumatoid arthritis

Sep. 24, 1998

Mitsui Chemicals prepares cell adhesion inhibitors

Sep. 24, 1998

PAF antagonist evaluated in patients with rheumatoid arthritis; results disappointing

Sep. 22, 1998

Novel antiinflammatory azulenes disclosed by Kotobuki

Sep. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...